We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $22.1B
1-Year Est. Return 45.54%
This Fund
S&P 500
This Quarter Est. Return
+4.23%
1 Year Est. Return
+45.54%
3 Year Est. Return
+139.2%
5 Year Est. Return
+180.26%
10 Year Est. Return
–
AUM
$9.35B
AUM Growth
+$149M
Cap. Flow
-$135M
Cap. Flow %
-1.45%
Top 10 Hldgs %
16.19%
Holding
2,678
New
110
Increased
434
Reduced
834
Closed
256

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$62.7M
2
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$20.5M
3
DOW icon
Dow Inc
DOW
+$10.9M
4
ENB icon
Enbridge
ENB
+$8.91M
5
CTVA icon
Corteva
CTVA
+$5.55M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$13.4M
2
MUB icon
iShares National Muni Bond ETF
MUB
+$12.8M
3
DD icon
DuPont de Nemours
DD
+$10.6M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$8.73M
5
MSFT icon
Microsoft
MSFT
+$8.71M

Sector Composition

Rank Sector Weight
1 Technology 16.75%
2 Financials 14.99%
3 Healthcare 13.12%
4 Industrials 10.24%
5 Consumer Discretionary 9.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CIR
1601
DELISTED
CIRCOR International, Inc
CIR
$407K ﹤0.01%
8,858
+1,567
+21% +$60.7K
THR
1602
DELISTED
Thermon Group Holdings
THR
$406K ﹤0.01%
15,847
– –
MGPI icon
1603
MGP Ingredients
MGPI
$381M
$406K ﹤0.01%
6,119
– –
HTLD icon
1604
Heartland Express
HTLD
$979M
$405K ﹤0.01%
22,410
– –
TCDA
1605
DELISTED
Tricida, Inc. Common Stock
TCDA
$405K ﹤0.01%
10,261
+1,457
+17% +$51.2K
PACB icon
1606
Pacific Biosciences
PACB
$357M
$404K ﹤0.01%
66,792
+9,086
+16% +$63.7K
ALDR
1607
DELISTED
Alder Biopharmaceuticals
ALDR
$404K ﹤0.01%
34,309
+9,263
+37% +$112K
CRC
1608
DELISTED
California Resources Corporation
CRC
$403K ﹤0.01%
20,491
– –
TELL
1609
DELISTED
Tellurian Inc.
TELL
$402K ﹤0.01%
51,257
+12,317
+32% +$109K
TDW icon
1610
Tidewater
TDW
$4.55B
$402K ﹤0.01%
17,119
+3,766
+28% +$86.6K
PLAN
1611
DELISTED
Anaplan, Inc.
PLAN
$401K ﹤0.01%
7,955
– –
TIVO
1612
DELISTED
Tivo Inc
TIVO
$401K ﹤0.01%
54,357
– –
LAB icon
1613
Standard BioTools
LAB
$312M
$400K ﹤0.01%
32,475
+16,371
+102% +$209K
UPWK icon
1614
Upwork
UPWK
$1.08B
$400K ﹤0.01%
24,847
+20,085
+422% +$346K
BJRI icon
1615
BJ's Restaurants
BJRI
$1.42B
$399K ﹤0.01%
9,083
– –
ENDP
1616
DELISTED
Endo International plc
ENDP
$399K ﹤0.01%
96,815
– –
AHRT
1617
AH Realty Trust
AHRT
$501M
$397K ﹤0.01%
23,985
+4,323
+22% +$70.4K
GPOR
1618
DELISTED
Gulfport Energy Corp.
GPOR
$397K ﹤0.01%
80,820
– –
SCSC icon
1619
Scansource
SCSC
$1.06B
$396K ﹤0.01%
12,162
– –
GCI
1620
DELISTED
Gannett Co., Inc
GCI
$395K ﹤0.01%
48,407
– –
PLOW icon
1621
Douglas Dynamics
PLOW
$981M
$393K ﹤0.01%
9,877
– –
CHEF icon
1622
Chefs' Warehouse
CHEF
$4.53B
$392K ﹤0.01%
11,175
+2,598
+30% +$85.6K
KELYA icon
1623
Kelly Services Class A
KELYA
$566M
$391K ﹤0.01%
14,944
– –
GOLF icon
1624
Acushnet Holdings
GOLF
$5.2B
$391K ﹤0.01%
14,893
– –
LMNX
1625
DELISTED
Luminex Corp
LMNX
$390K ﹤0.01%
18,901
– –
63 64
65
66 67

Similar funds

BA
Bridgewater Associates Westport, Connecticut $22.4B AUM 34.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $20.7B AUM 292.88% 1-Year Est. Return
CHP
Castle Hook Partners New York $23.4B AUM 158.96% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

MetLife Investment Management's Q2 2019 Portfolio in Review

As of Q2 2019, MetLife Investment Management held 2,678 positions worth $9.35B, up 1.6% from $9.2B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

MetLife Investment Management's Q2 2019 filing shows 110 new, 434 increased, 834 reduced and 256 closed positions. Its largest new stake was Dow Inc: 206,405 shares worth $10.2M. The largest sale was Apple, an estimated $13.4M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q2 2019 buy was Dow Inc: 206,405 shares worth $10.2M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2019, an estimated $62.7M increase.
  • MetLife Investment Management's biggest Q2 2019 reduction was Apple, cutting an estimated $13.4M.
  • MetLife Investment Management fully exited iShares National Muni Bond ETF in Q2 2019, selling an estimated $12.8M.
  • MetLife Investment Management's ten largest holdings make up 16% of its $9.35B portfolio in Q2 2019.
  • MetLife Investment Management opened 110 new positions and closed 256 in Q2 2019.
  • MetLife Investment Management's portfolio value rose 1.6% quarter-over-quarter to $9.35B.

Based on MetLife Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.